Vaccine News and Research

Latest Vaccine News and Research

Small increases in temperature, rainfall amount can predict cholera outbreaks, study says

Small increases in temperature and rainfall amount may be able to predict cholera outbreaks in some areas, according to a study published in the June issue of the American Journal of Tropical Medicine and Hygiene, Agence France-Presse reports.

2 Jun 2011

PCR-based saliva test can accurately identify cytomegalovirus infection in newborns

Although cytomegalovirus infection is a known cause of birth defects, including permanent hearing loss, most CMV infections in infants are not identified early, when interventions can lessen the effects of hearing loss.

2 Jun 2011

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.

1 Jun 2011

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted the Company's request for Priority Review of its supplemental Biologics License Application for Soliris as a treatment for patients with atypical Hemolytic Uremic Syndrome.

1 Jun 2011

Experts to present latest information on paediatric infectious diseases at ESPID 2011

The Annual ESPID Meeting has become the world's largest meeting in the field of Paediatric Infectious Diseases (PID): it provides the latest information on the number one threat to global child health.

1 Jun 2011

MMRGlobal, VZJ to launch consumer and professional health IT products

MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.

1 Jun 2011

UNICEF publishes vaccine costs in an effort to promote price competition

UNICEF for the first time on Friday published the prices it pays pharmaceutical companies for vaccines, "as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs," the Associated Press/Washington Post reports (5/28).

1 Jun 2011

Lymphoma vaccine extends disease-free survival by 14 months

A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University of Texas MD Anderson Cancer Center reported today in the online version of Journal of Clinical Oncology.

1 Jun 2011

NIH scientists discuss expanded HIV testing and new prevention tools

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease.

1 Jun 2011

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

With recent deadly cholera outbreaks in Haiti and Cameroon providing the latest indication of a menacingly resurgent disease, scientists have discovered rain and temperature fluctuations in at-risk areas could predict epidemics months in advance, according to a new study published today in the June 2011 issue of the American Journal of Tropical Medicine and Hygiene.

1 Jun 2011

AIDS epidemic turns 30

It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.

31 May 2011

Scientists develop carbohydrate-based vaccine against C. difficile infection

There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max Planck Institute of Colloids and Interfaces in Potsdam has developed a vaccine based on a carbohydrate against the Clostridium difficile bacterium, which is known to cause serious gastrointestinal diseases mainly in hospitals.

31 May 2011

Flu vaccines at the ready this season

Manufacturers of flu vaccines are nearly ready with the new supply of vaccinations for this upcoming flu season in the northern hemisphere. Two weeks ago, five vaccine manufacturers announced plans to make between 166 million and 173 million doses for the coming season. That's at least 6 million more than the maximum ever produced. However they add that many might not actually need the shots.

29 May 2011

Appointment of drug company to GAVI board draws criticism from NGOs

The appointment of Dutch pharmaceutical company Crucell, recently acquired by Johnson & Johnson, to the board of the GAVI Alliance is "sparking concerns over conflicts of interest and demands for tougher competition to reduce prices," the Financial Times reports.

27 May 2011

Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS

Emergent BioSolutions Inc. today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) for inclusion in the Strategic National Stockpile (SNS) over a 5 year period.

27 May 2011

Nature special issue focuses on vaccines

The May 26 issue of Nature explores vaccines, which the journal says "are responsible for some of the world's greatest public health triumphs." Though new vaccines for deadly diseases have been developed in the past 10 years, and more are in development, "funding is tight, and unfounded doubts about the safety of vaccines persist." The issue features stories on polio, measles, HIV/AIDS, tuberculosis and malaria, as well as issues surrounding vaccine rejection and hysteria about risk.

27 May 2011

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.

27 May 2011

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

CEL-SCI Corporation today announced the positive results of efficacy studies in mice of L.E.A.P.S.TM H1N1 activated dendritic cells to treat the H1N1 virus.

27 May 2011

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

Krista and Tatiana are not like most other sets of twins. They are connected at their heads, where their skulls merge under a mass of shaggy brown bangs. The girls run and play and go down their backyard slide, but whatever they do, they do together, their heads forever inclined toward each other's, their neck muscles strong and sinuous from a never-ending workout. Twins joined at the head — the medical term is craniopagus — are extremely rare.

27 May 2011

Vaccine News and Research

Latest Vaccine News and Research

Small increases in temperature, rainfall amount can predict cholera outbreaks, study says

PCR-based saliva test can accurately identify cytomegalovirus infection in newborns

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS

Experts to present latest information on paediatric infectious diseases at ESPID 2011

MMRGlobal, VZJ to launch consumer and professional health IT products

UNICEF publishes vaccine costs in an effort to promote price competition

Lymphoma vaccine extends disease-free survival by 14 months

NIH scientists discuss expanded HIV testing and new prevention tools

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

AIDS epidemic turns 30

Scientists develop carbohydrate-based vaccine against C. difficile infection

Flu vaccines at the ready this season

Appointment of drug company to GAVI board draws criticism from NGOs

Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS

Nature special issue focuses on vaccines

Research provides new understanding of how heroin affects the brain

Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in